At the news
? NEUTRALIMPACT 3/10 SC 13G/A filed Nov 5, 2026 at 13:27 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting a 7.7% passive stake in Veracyte as of September 30, 2026, up from the prior filing's 5%+ disclosure. The increase reflects routine portfolio rebalancing by a large passive asset manager and follows Veracyte's Q3 earnings report showing 15% revenue growth and a new $100M buyback authorization.
- FMR LLC reported beneficial ownership of 6,172,996.40 shares of Veracyte common stock, representing 7.7% of shares outstanding as of September 30, 2026.
- This is an amendment to a Schedule 13G, confirming passive investment intent under Rule 13d-1(b).
- The prior FMR LLC filing (June 5, 2026) reported ownership of 5% or greater but did not specify the exact percentage; the new filing shows an increase to 7.7%.
- Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or greater of the outstanding shares.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access